Westicke Partners

Is the Biotech IPO Market Coming Back? How to Prepare

Posted on August 23rd, 2022. Posted by Kate Coyle and Darcie Robinson

The second quarter of 2022 was the weakest quarter for healthcare and biotech IPOs in more than five years. Some media headlines have predicted that it marked the bottom of the biotech market. 

The XBI biotech index fund, which serves as an index for many companies that are eyeing a public debut, peaked in January 2021 followed by a fairly steady 16-month decline. But now, the XBI is on the rise. While it’s too soon to know if the XBI rise that kicked off in July 2022 will continue to mirror the rise that drove its 2021 peak, the climb appears to be signaling a comeback of healthcare and biotech IPOs.  

If you’re watching the fund, you might now be considering reviving your plans to take your company public.

Continue Reading

Tweet

Healthcare Communications: The Impact of the Pandemic

Posted on November 16th, 2020. Posted by Kate Coyle

After nearly 20 years of working in healthcare communications, the excitement never gets old for me. What’s not to love about an industry that’s critical to life itself, rife with issues and controversy, and delivers a solid dose of the unexpected on a daily basis?
In my mind, a highlight is the problem solving our job requires every day. Whether pursuing an opportunity, managing an issue or leveraging an insight, it’s our responsibility to chart the path forward on behalf of our clients.

Continue Reading

Tweet